Harnessing the U.S. Taxpayer to Fight Cancer and Make Profits

By MATT RICHTEL and ANDREW POLLACK from NYT Health http://ift.tt/2hjPPDW
via IFTTT
Public funding is backing a new immunotherapy treatment, but the bulk of any profits will go to a private company. So are taxpayers getting a good deal?
Harnessing the U.S. Taxpayer to Fight Cancer and Make Profits - By MATT RICHTEL and ANDREW POLLACK - at Health - Keyword: Drugs (Pharmaceuticals) - From The New York Times - Published at December 19, 2016 at 07:00AM